| Sezary Syndrome studied in …STUDIED_INderived56 of 56show fewer |
|---|
| → studied in | NCT05944562Phase 1 · active not recruiting Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07003100recruiting A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04930653Phase 2 · recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904146recruiting Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03011814Phase 1/Phase 2 · recruiting Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256018Phase 2 · recruiting Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04960618Phase 2 · active not recruiting Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06113081completed Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07535710Phase 1/Phase 2 · not yet recruiting Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587844Phase 2 · recruiting Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07477769not yet recruiting Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00177268recruiting Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05157581recruiting Extracorporeal Photopheresis in Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06588868recruiting Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02840747recruiting Tissue Repository: CTCL Collection Protocol · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541017Phase 1/Phase 2 · terminated Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213882early Phase 1 · not yet recruiting A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234048Phase 1 · recruiting Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132567recruiting Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03695471Phase 2 · completed Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879458Phase 2 · terminated Ritlecitinib in CTCL · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04312841Phase 2 · completed Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953301Phase 2 · completed Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676087Phase 1/Phase 2 · terminated Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02836886completed VircapSeq Virus Detection in Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047060Phase 1/Phase 2 · completed Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00896493Phase 2 · completed Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185220Phase 1 · completed Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811783Phase 3 · terminated Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905135Phase 1 · completed Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03646422unknown AEDV Registry of Primary Cutaneous Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04955340Phase 1 · completed A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05206045unknown Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02341209Phase 2 · terminated Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134341Phase 1 · completed Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02822586Phase 1 · completed TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373305Phase 1 · withdrawn Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02542124Phase 2 · unknown NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625455Phase 4 · terminated Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091559Phase 2 · completed Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396070Phase 2 · completed Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00611208Phase 2 · completed A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00178841Phase 2 · completed Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099593Phase 2 · completed Immunization Against Tumor Cells in Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254332completed Effect of Denileukin Diftitox on Immune System in CTCL Patients · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00177190completed In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00748319NA · completed Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00127881Phase 3 · terminated Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050999Phase 4 · completed Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00051012Phase 4 · completed Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00157274Phase 2 · unknown Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |